SCHEMBL6505475

SCHEMBL6505475

[CH2]NC(=O)c1cc(Cl)nc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.56
TAS1R1 Q7RTX1 1/20 0.56
TAS1R2 Q8TE23 1/20 0.56
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.41
CYP1A2 P05177 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
ACKR3 P25106 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
GAA P10253 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5480908 0.84 ALDH1A1 (0.57) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL6970353 0.82 S1PR2 (0.47) TAS1R3TAS1R1TAS1R2ALDH1A1RAB9A
SCHEMBL567975 0.81 ALDH1A1 (0.76) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL31287794 0.81 ALDH1A1 (0.76) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL6964278 0.80 ALDH1A1 (0.58) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL837798 0.80 ALDH1A1 (0.56) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL931870 0.80 ALDH1A1 (0.52) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL5761347 0.80 ALDH1A1 (0.52) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL661794 0.79 TAS1R3 (0.69) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E
SCHEMBL13570729 0.78 ALDH1A1 (0.50) TAS1R3TAS1R1TAS1R2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed